TYK Medicines Inc

TYK Medicines Inc has a liquidity position characterized by a current ratio of 1.43, indicating that the company has sufficient current assets to cover its current liabilities. The company's cash and equivalents amount to CNY 367.29 million, which is a significant portion of its total assets of CNY 779.74 million. However, the company's operating cash flow is negative at CNY -215.77 million, and its free cash flow is also negative at CNY -326.18 million, suggesting that the company is not generating positive cash flow from its operations. The company's profitability is currently negative, with a return on equity of -1.0457 and a return on assets of -0.3844. The net income for the period is CNY -299.77 million, and the operating income is CNY -291.06 million, indicating that the company is not profitable. The debt-to-equity ratio is 0.53, suggesting that the company is not heavily leveraged. TYK Medicines Inc does not report revenue in its latest financial snapshot, which is a concern for its revenue concentration and geographic exposure. The absence of revenue data makes it difficult to assess the company's market share and geographic diversification. The company's total liabilities amount to CNY 493.07 million, with long-term debt at CNY 152.81 million. The growth trajectory of TYK Medicines Inc is uncertain, as the company's latest actual revenue is reported as CNY 0.00, and the last actual EPS is CNY -0.80. The company's capital expenditure is CNY -45.22 million, indicating that it is investing in its operations. However, the lack of revenue data and the negative net income suggest that the company is not currently growing. The risk assessment for TYK Medicines Inc indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is not heavily leveraged, and its cash and equivalents are sufficient to cover its current liabilities. However, the company's negative operating and free cash flows are a concern for its liquidity position. Recent events and filings for TYK Medicines Inc do not provide specific details, but the company's financial performance indicates that it is not currently generating revenue and is experiencing losses. The company's total equity is CNY 286.67 million, and its total assets are CNY 779.74 million, suggesting that the company has a moderate asset base.